Page last updated: 2024-09-03

sdz 220-581 and Anochlesia

sdz 220-581 has been researched along with Anochlesia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
McAllister, KH	1

Other Studies

1 other study(ies) available for sdz 220-581 and Anochlesia

Article	Year
The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats. European journal of pharmacology, 1996, Oct-31, Volume: 314, Issue:3 Topics: Animals; Antipsychotic Agents; Binding, Competitive; Biphenyl Compounds; Catalepsy; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Haloperidol; Male; Molecular Structure; Neuroprotective Agents; Propionates; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Statistics, Nonparametric; Structure-Activity Relationship	1996

Article

Year

The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats.

European journal of pharmacology, 1996, Oct-31, Volume: 314, Issue:3

Topics: Animals; Antipsychotic Agents; Binding, Competitive; Biphenyl Compounds; Catalepsy; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Haloperidol; Male; Molecular Structure; Neuroprotective Agents; Propionates; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Statistics, Nonparametric; Structure-Activity Relationship

1996